TNFRSF17 expression was restricted to plasma cell high tumours regardless of the presence of other tumour-infiltrating lymphocytes (T cells, memory B cells) and linked to an improved survival in ovarian cancer [74]. Here, TNFRSF17 is linked to neoplasm.